Pleural Effusion in Dasatinib-Treated Patients With Chronic Myeloid Leukemia in Chronic Phase: Identification and Management

Clinical Lymphoma, Myeloma and Leukemia - United States
doi 10.1016/j.clml.2016.09.012
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Management of Chronic Myeloid Leukemia in Advanced Phase

Frontiers in Oncology
Cancer ResearchOncology
2019English

The Role of Dasatinib in the Management Of chronic Myeloid Leukemia

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2015English

Starting With a Lower Daily Dose of Dasatinib in Patients With Chronic Myeloid Leukemia in Chronic Phase: Less Is More, or Is It?

Cancer
Cancer ResearchOncology
2018English

Cost-Effectiveness of Dasatinib and Nilotinib for Imatinib-Resistant or -Intolerant Chronic Phase Chronic Myeloid Leukemia

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2011English

Dasatinib in the Treatment of Imatinib Refractory Chronic Myeloid Leukemia

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2009English

Reply to Starting With a Lower Daily Dose of Dasatinib in Patients With Chronic Myeloid Leukemia in Chronic Phase: Less Is More, or Is It?

Cancer
Cancer ResearchOncology
2018English

Long-Term Safety and Efficacy of Dasatinib in the Treatment of Chronic-Phase Chronic Myeloid Leukemia Patients Resistant or Intolerant to Imatinib

Blood and Lymphatic Cancer: Targets and Therapy
2014English

Therapeutic Drug Monitoring of Imatinib, Nilotinib, and Dasatinib for Patients With Chronic Myeloid Leukemia

Biological and Pharmaceutical Bulletin
MedicinePharmacologyPharmaceutical Science
2015English

Gynecomastia in a Male After Dasatinib Treatment for Chronic Myeloid Leukemia

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy